Skip to search formSkip to main contentSkip to account menu

ZNF154 gene

Known as: ZINC FINGER PROTEIN 154, ZNF154, pHZ-92 
National Institutes of Health

Related topics

Related topics

1 relation
Zinc Fingers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common and among the deadliest of pancreatic cancers. Its 5-year survival is… 
2019
2019
Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer
Here we conducted an evidence-based study in developing and validating a urinary biomarker combination of gene methylation assays… 
2018
2018
ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
2017
2017
Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling
Background Nasopharyngeal carcinoma (NPC) is especially prevalent in southeast Asia and southern China, but its molecular… 
2016
2016
Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.
Highly Cited
2015
Highly Cited
2015
An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese
To develop a routine and effectual procedure of detecting bladder cancer (BlCa), an optimized combination of epigenetic… 
2013
2013
Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines
The study of aberrant DNA methylation in cancer holds the key to the discovery of novel biological markers for diagnostics and… 
Highly Cited
2012
Highly Cited
2012
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
Background Non muscle invasive bladder cancer (NMIBC) has the highest recurrence rate of any malignancy and as many as 70% of… 
Highly Cited
2012
Highly Cited
2012
Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
To clarify the significance of DNA methylation alterations during renal carcinogenesis, methylome analysis using single-CpG… 
Highly Cited
2011
Highly Cited
2011
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Purpose: Epigenetic alterations are common and can now be addressed in a parallel fashion. We investigated the methylation in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)